Greifswald / Levallois-Perret, 03. April 2024
Caroline Jacquin will take over the management of CHEPLAPHARM France, based in Levallois-Perret, a subsidiary of the CHEPLAPHARM Group from Greifswald/Germany, in April 2024. The previous Managing Director of CHEPLAPHARM France, Isabelle Dalle, is retiring.
Caroline Jacquin, an experienced pharmaceutical manager, is taking over the position as Managing Director of the French subsidiary. Caroline can look back on 25 years of experience in leading positions in different pharmaceutical companies in France, Singapore and Mexico. Most recently, she was Marketing and Sales Director at MSD France, where she was leading the Hospital business unit.
The previous Managing Director of CHEPLAPHARM in France, Isabelle Dalle, is taking her well-deserved retirement. She has managed the French subsidiary since its foundation in 2016.
"I am delighted that we have been able to fill the position of the Managing Director of CHEPLAPHARM France with such a high-profile candidate as Caroline Jacquin. With her expertise in the French pharmaceutical market and her international career, Caroline Jacquin is a perfect fit for us and for our French subsidiary, which is important for the entire group," says Edeltraud Lafer, CEO of CHEPLAPHARM Arzneimittel GmbH. "I would like to expressly thank Isabelle Dalle for the work she has done. She has managed the French subsidiary since its foundation with vision and a pioneering spirit and, together with her team, has developed our subsidiary into a central unit of the CHEPLAPHARM Group."
Caroline Jacquin has been Deputy Managing Director at CHEPLAPHARM France since 1 March 2024 and will take over full responsibility from Isabelle Dalle on 1 April, who will remain available to the company in an advisory capacity until the end of the year.